| (210) | Number of the EPO application | 18702642 |
| (220) | Filing date of the EPO application | 2018.01.26 |
| (80) | EPO patent specification publication (B) | EPB nr. 14/2023, 2023.04.05 |
| (110) | EPO patent number | 3573647 |
| (21) | Number of the application | e 2019 1325 |
| (71) | Name(s) of applicant(s), code of the country | IMMATICS BIOTECHNOLOGIES GMBH, DE; |
| (72) | Name(s) of inventor(s), code of the country | SCHUSTER Heiko, DE;
PEPER Janet, DE;
RÖHLE Kevin, US;
WAGNER Philipp, DE;
RAMMENSEE Hans-Georg, DE; |
| (73) | Name(s) of owner(s), code of the country | IMMATICS BIOTECHNOLOGIES GMBH, DE; |
| (54) | Title of the invention | NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST OVARIAN CANCER AND OTHER CANCERS |
| (13) | Kind-of-document code | A1 |
| (51) | International Patent Classification | A61K 39/00 (2006.01.01); C07K 14/705 (2006.01.01); C07K 14/47 (2006.01.01); C07K 7/06 (2006.01.01); C07K 7/08 (2006.01.01) |
| (19) | Country | DE |
| (41) | Date of publication of the application | 2020.01.31 |
| (30) | Priority | 102017101671, 2017.01.27, DE; 201762451255 P, 2017.01.27, US |
| (86) | International application | PCT/EP2018/051952, 2018.01.26 |
| (87) | International publication | WO 2018/138257, 2018.08.02 |